Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry

Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.
Source: NYT Health - Category: Consumer Health News Authors: Tags: United States Drugs for Neglected Diseases Initiative Shkreli, Martin (1983- ) Centers for Disease Control and Prevention Drugs (Pharmaceuticals) Food and Drug Administration Chagas Disease Latin America Turing Pharmaceuticals AG Prices Source Type: news